Versus helps power the in-stadium fan experience at Sanford Stadium for the 5th straight season
LOS ANGELES, Sept. 23, 2021 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus” or the “Company”) (Nasdaq: VS) announced today that The University of Georgia Bulldogs, currently ranked #2 in the Associated Press Top 25 College Football Rankings, is working with Versus Systems to get over 90,000 fans excited and engaged at each of their home games in Sanford Stadium this season.
This is the fifth straight year that Versus has been working with the UGAA for in-stadium engagement, bringing custom video board tools to entertain fans during Bulldogs home football, basketball, gymnastics, and volleyball games.
“Georgia is a great football team, a perennial contender for the national title, and a force in the SEC. The Georgia fans at Sanford Stadium are a fantastic crowd and we are excited to work with the team again this year,” said Matthew Pierce, Founder and CEO of Versus Systems.
About Versus Systems
Versus Systems Inc. has developed a proprietary prizing and promotions engine that allows publishers, developers, and creators of streaming media, live events, broadcast TV, games, apps, and other content to offer real world prizes inside their content. Audiences can choose from among the offered prizes and then complete in-game or in-app challenges to win the prizes. The Versus platform can be integrated into streaming media, TV, mobile, console, and PC games, as well as mobile apps. For more information, please visit www.versussystems.com or visit the official Versus Systems YouTube channel.
Cody Slach and Sophie Pearson
Gateway Investor Relations
Disclaimer for Forward-Looking Information
This news release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are forward looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward looking statements. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking statements and information. There can be no assurance that forward-looking information, or the material factors or assumptions used to develop such forward-looking information, will prove to be accurate. The Company does not undertake any obligations to release publicly any revisions for updating any voluntary forward-looking statements, except as required by applicable law.
- Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice President, head of business development - September 21, 2023
- The Growing Popularity of Veganism Accelerates Brewer Yeast Powder Market Sales with Anticipated CAGR of 6.7% in 2033 | FMI - September 21, 2023
- Feldspar and Nepheline Syenite Market revenue to hit USD 7 Billion by 2033, says Research Nester - September 21, 2023